Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
23/06/2026 07:11
BRIEF-Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan June 23 (Reuters) - Pharma Mar SA PHMR.MC:
MERCK SUBMITS ZEPZELCA REGISTRATION DOSSIER TO JAPAN MHLW (MINISTRY OF HEALTH, LABOUR AND WELFARE) FOR FIRST-LINE MAINTENANCE IN SCLC
ZEPZELCA NDA RECEIVES PRIORITY REVIEW DESIGNATION IN JAPAN
Source text
Further company coverage: PHMR.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Pharma Mar SA
See all newsBrief: Pharma Mar Starts Share Buyback Of Up To 90,000 Shares, 0.5% of Its Capital
Spanish stocks - Factors to watch on June 23
Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
Europe Research Roundup: Assa Abloy, DHL, Randstad
Spanish stocks - Factors to watch on June 16